SPONSOR
Zhujiang Hospital
Total Trials
10
Recruiting
10
Phases
Phase 1, Phase 2
Conditions studied: Monoclonal Gammopathy of Undetermined Significance (MGUS)Intestinal FloraMultiple MyelomaM-ProteinM ProteinAcute LeukemiaIntracranial AneurysmSubarachnoid Hemorrhage, AneurysmalCerebral AneurysmBrain Aneurysm
Zhujiang Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Monoclonal Gammopathy of Undetermined Significance (MGUS), Intestinal Flora, Multiple Myeloma, M-Protein.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhujiang Hospital
How many clinical trials has Zhujiang Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Zhujiang Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Monoclonal Gammopathy of Undetermined Significance (MGUS), Intestinal Flora, Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhujiang Hospital research focus on?
Zhujiang Hospital clinical trials span Monoclonal Gammopathy of Undetermined Significance (MGUS), Intestinal Flora, Multiple Myeloma, M-Protein, M Protein, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhujiang Hospital clinical trial?
To participate in a Zhujiang Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhujiang Hospital trials with current recruitment status updated daily.
Clinical Trials by Zhujiang Hospital
NCT06690593
Recruiting
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06082284
Recruiting
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
Multiple Myeloma
NCT07362095 Phase 1, Phase 2
Recruiting
Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)
Acute Leukemia
NCT06456814
Recruiting
Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China
Intracranial Aneurysm
NCT06266897
Recruiting
A Study on the Correlation Between Endometriosis and Intra-tissue Microbiota
Endometriosis
NCT07111455
Recruiting
Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy
Locally Advanced Oral Squamous Cell Carcinoma
NCT06726460
Recruiting
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
Electrolyte Disorder
NCT05628987
Recruiting
The Association of Gut Microbiota and Spermatogenic Dysfunction
Infertility, Male
NCT06097065
Recruiting
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Prediabetes
NCT06902012 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology